Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
BJU International
Published October 4, 2026
Global trends in urological cancers: an analysis of the global burden of disease study 2023.
October 5, 2026
Medspoke
Medspoke
BJU International
Published October 4, 2026
00:00
--:--
Gleason pattern 4 length and active surveillance eligibility in Grade Group 2-4 prostate cancer.
October 5, 2026
Share
Gleason pattern 4 length and active surveillance eligibility in Grade Group 2-4 prostate cancer.
https://www.medspoke.co/channel_journal?id=689&tap_id=15049
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Journal of Clinical Endocrinology & Metabolism (JCEM)
Published October 5, 2026
Functional Hypothalamic Amenorrhea Phenotype and Cardiovascular Disease Risk.
October 5, 2026
Why are you reporting this TALK?